Axogen Inc (AXGN) financials

NASDAQ · Health Care

$49.37 -0.52% Close Oct 30, 2026 Live

Axogen revenue and earnings by year

Axogen's revenue was $225 million in the fiscal year to December 31, 2025, up 20.2% from the year before. Net income was -$15.7 million, -7.0% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 20.8% a year on average.

RevenueNet income
$0$100M$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue225187159139127112107846041
Revenue growth20.2%17.8%14.7%8.8%13.4%5.2%27.1%38.9%47.0%—
Gross profit1671421221091049189715135
Gross margin74.3%75.8%76.6%78.5%82.0%80.8%83.7%84.6%84.6%84.3%
Operating income-8-3-21-30-25-23-31-21-8-8
Operating margin-3.5%-1.8%-13.5%-21.4%-20.0%-20.6%-29.4%-24.4%-13.2%-19.8%
Net income-16-10-22-29-27-24-29-22-10-14
Net margin-7.0%-5.3%-13.7%-20.9%-21.2%-21.2%-27.3%-26.7%-17.3%-35.1%
Diluted EPS-$0.34-$0.23-$0.51-$0.69-$0.65-$0.60-$0.74-$0.60-$0.30-$0.47
Free cash flow-31-20-36-41-32-25-24-10-12

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open AXGN in Markets.

See also: AXGN returns

No forecast, no recommendation. This page describes Axogen Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.